Ultrasound Workspace (UWS 6.0) vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Tempus AI, Inc.

AI Verdict

Tool A is a comprehensive echocardiography viewing, analysis, and reporting system designed to streamline workflows and enhance diagnostic confidence for ultrasound imaging. Tool B is an AI-based algorithm specifically designed to analyze 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within the next 12 months. While both are cardiology AI tools, they address different diagnostic modalities and clinical objectives, making them adjacent rather than direct competitors.

Choose Ultrasound Workspace (UWS 6.0) if…

Choose Philips Ultrasound Workspace (UWS 6.0) if your cardiology department requires a comprehensive, scalable solution for advanced echocardiography viewing, analysis, and reporting. This tool is ideal for standardizing workflows, enhancing diagnostic confidence through AI-powered automated measurements, and integrating multi-vendor data for consistent on- and off-cart diagnostic capabilities.

View Ultrasound Workspace (UWS 6.0) →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your facility aims to proactively identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation within the next 12 months using standard 12-lead ECG recordings. This AI-based algorithm supports earlier intervention and follow-up for a specific patient population, leveraging existing ECG infrastructure.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ultrasound Workspace (UWS 6.0) Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment On-premise (single-seat workstation, multi-seat server) Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ultrasound Workspace (UWS 6.0)

Philips Ultrasound Workspace (UWS 6.0) is described as a 'holistic' system designed to 'streamline echocardiography workflows' with 'web-based access for remote image review, analysis, and reporting'. Its emphasis on consistent on- and off-cart capabilities and integration with PACS and EMR systems suggests a more comprehensive and flexible user experience aimed at improving workflow efficiency.

Clinical Value

Tempus ECG-AF

Tempus ECG-AF offers a novel predictive capability by identifying patients at increased risk of developing atrial fibrillation/flutter within 12 months, which can support earlier identification and follow-up. This provides a distinct clinical insight beyond enhancing existing workflows, potentially enabling proactive intervention for a specific, impactful condition.

Pricing & Value

Tempus ECG-AF

While both tools require contacting the vendor for pricing, Tempus ECG-AF explicitly mentions CMS reimbursement availability with specific CPT codes and a Medicare rate. This transparency regarding potential reimbursement pathways provides a clear financial value proposition for healthcare providers, which is absent in Tool A's general mention of 'flexible licensing models'.

Enterprise Readiness

Ultrasound Workspace (UWS 6.0)

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating foundational readiness. However, Tool A explicitly details a 'scalable technology platform,' 'server-client network infrastructure,' and 'integration with existing PACS and EMR systems,' along with web-based access, suggesting a more robust and flexible deployment strategy for diverse enterprise environments.

Innovation

Tempus ECG-AF

Tool A focuses on automating and standardizing existing echocardiography measurements across vendors, which is valuable for efficiency. Tool B, however, presents a more innovative application of AI by providing a predictive algorithm for identifying patients at risk of new-onset Atrial Fibrillation within a 12-month window, offering a novel diagnostic insight.

Support & Docs

Tie

The provided structured facts do not contain specific details regarding the support services or documentation for either product. Without comparative information on the scope, availability, or quality of support and documentation, it is not possible to definitively pick a winner between the two tools.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ultrasound Workspace (UWS 6.0) Tempus ECG-AF
Name Ultrasound Workspace (UWS 6.0) Tempus ECG-AF
Company Philips Ultrasound Tempus AI, Inc.
Primary Function AI-powered cardiovascular viewing, analysis, and reporting system for echocardiography workflows. AI-based algorithm analyzing 12-lead ECGs to identify patients (65+) at increased risk of developing Atrial Fibrillation/flutter (AF) within 12 months.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Critical Care, Radiology Cardiology, Geriatrics, Internal Medicine
Key Differentiating Feature AI-powered automated measurements (e.g., Auto Measure, AutoStrain LV, 3D Auto RV, 3D Auto MV, 3D Auto TV, 3D Auto CFQ); Vendor-neutral and multi-vendor data analysis. AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months for patients 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.

Videos

Demos, reviews, and walkthroughs featuring Ultrasound Workspace (UWS 6.0) and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Philips Ultrasound Workspace (UWS 6.0) is a comprehensive system for cardiovascular viewing, analysis, and reporting, specifically designed to streamline echocardiography workflows and enhance diagnostic confidence. In contrast, Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Philips Ultrasound Workspace (UWS 6.0) utilizes AI for automated measurements in echocardiography, such as Auto Measure, AutoStrain LV, and 3D Auto RV, aiming to improve reproducibility and reduce variability. Tempus ECG-AF, on the other hand, employs an AI-based algorithm to analyze 12-lead ECGs for predictive risk assessment, specifically identifying the likelihood of new-onset atrial fibrillation within a year.
Philips Ultrasound Workspace (UWS 6.0) is designed for comprehensive cardiovascular data analysis from echocardiograms, supporting various cardiac imaging needs. Tempus ECG-AF is specifically intended for analyzing 12-lead ECG recordings from patients aged 65 or older who do not have pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to assess their risk of developing AF.
Yes, CMS reimbursement is available for Tempus ECG-AF, with CPT codes 0764T and 0765T assigned to APC 5734, at a Medicare rate of $128.90, effective January 1, 2025. For Philips Ultrasound Workspace (UWS 6.0), pricing details require contacting a Philips representative.
Philips Ultrasound Workspace (UWS 6.0) explicitly features vendor-neutral and multi-vendor data analysis, which helps in standardizing echocardiography workflows and enhancing diagnostic confidence. The provided information for Tempus ECG-AF does not specify vendor-neutral data analysis, but it is compatible with specific FDA authorized ECGs from GE and Philips.
Philips Ultrasound Workspace (UWS 6.0) supports Cardiology, Critical Care, and Radiology. Tempus ECG-AF is primarily intended for use in Cardiology, Geriatrics, and Internal Medicine, focusing on the identification of AF risk in older patients.
AI Tool Finder
AI-powered search. Results may not be comprehensive.